This is a regulatory intimation submitted to the National Stock Exchange of India Limited and BSE Limited.
The Board of Directors of KRONOX Lab Sciences Limited has scheduled a meeting to be held on Thursday, November 05, 2026. The primary agenda for this meeting is to consider and approve the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026.
The disclosure also confirms that the Trading Window for trading in the company's securities has been closed for Directors, Officers, and designated employees of the Company. The closure became effective from October 01, 2026, and is stipulated to remain closed until 48 hours after the declaration of the aforementioned Unaudited Standalone Financial Results.
This intimation is made in continuation of a previous announcement and is pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable regulations.
The letter is signed by Nikhil Goswami, Company Secretary & Compliance Officer (Membership No. A68272), on behalf of KRONOX Lab Sciences Limited.